| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/09/2001 | EP1014959A4 Agmatine as a treatment for neuropathic pain |
| 05/09/2001 | EP0907351B1 Cosmetic or cosmetic preparation for smoothing and tightening the skin in the case of subcutaneous fatty tissue problems, particularly cellulite |
| 05/09/2001 | EP0858441B1 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders |
| 05/09/2001 | EP0855397B1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same |
| 05/09/2001 | EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/09/2001 | EP0792152A4 Compositions and methods for contraception and for treatment of benign gynecological disorders |
| 05/09/2001 | EP0776206B1 Pharmaceutical formulation containing amoxycillin and potassium clavulanate |
| 05/09/2001 | EP0749432B1 9-deoxotaxane compounds |
| 05/09/2001 | EP0684842B1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 05/09/2001 | EP0633776B1 Compounds useful for treating allergic and inflammatory diseases |
| 05/09/2001 | EP0450040B1 Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base |
| 05/09/2001 | CN1294632A Compsns. derived from i(mycobacterium vaccae) and methods for their use |
| 05/09/2001 | CN1294630A Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth |
| 05/09/2001 | CN1294593A Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 05/09/2001 | CN1294592A Process for preparing (-) pyridobenzoxazine carboxylic acid derivatives |
| 05/09/2001 | CN1294591A Process for prodn. of purine derivatives |
| 05/09/2001 | CN1294590A Method of 3-substituted adenines via 2-thioxanthines |
| 05/09/2001 | CN1294587A Benzo [B] pyran derivatives useful as external agents for skin |
| 05/09/2001 | CN1294582A Novel nucleic acid trangsfer agents, compsns, contg. same and uses |
| 05/09/2001 | CN1294581A Pyridine derivative and pharmaceutical contg. same |
| 05/09/2001 | CN1294580A Indole derivatives with antiviral activity |
| 05/09/2001 | CN1294579A Sulfonamide-contg. indole compounds |
| 05/09/2001 | CN1294578A Novel naphthyl-substituted and anilide-substituted sulfonanides |
| 05/09/2001 | CN1294577A 钾通道抑制剂 Potassium channel inhibitors |
| 05/09/2001 | CN1294576A VLA-4 antagonists |
| 05/09/2001 | CN1294520A Polynucleotide compsn. method of prepn. and use thereof |
| 05/09/2001 | CN1294519A Pharmaceutical Compsns. contg. compounds with activity for enhancement of absorption of active ingredients |
| 05/09/2001 | CN1294518A Remidies for hepatitis |
| 05/09/2001 | CN1294516A Antitumor compsn. contg. synergistic compsn. of anthracycline derivative with camptothecin derivate |
| 05/09/2001 | CN1294515A Compsn. for reducing serum cholesterol levels |
| 05/09/2001 | CN1294514A Steroid derived antibiotics |
| 05/09/2001 | CN1294513A Pharmaceutically active morpholinol |
| 05/09/2001 | CN1294512A Paroxetine compsns. |
| 05/09/2001 | CN1294511A Medicinal compsns. |
| 05/09/2001 | CN1294509A Enteric coated pharmaceutical compsn. and method of mfg. |
| 05/09/2001 | CN1294196A Immune stimulated holoside substance of bacterial strain from wood layer hole strain and its application |
| 05/09/2001 | CN1294133A Process for extracting cordycepin and its preparation |
| 05/09/2001 | CN1294017A Ceramide lipsome emulsion containing VA and its preparing process and usage |
| 05/09/2001 | CN1294015A Medicine for treating thyroid enlargement and thyroidism |
| 05/09/2001 | CN1293993A Styptic and inflammation-relieving medicine and its preparing process |
| 05/09/2001 | CN1293968A Coptis liquid for relieving inflammation and moistening skin and its preparing process |
| 05/09/2001 | CN1293966A Health-care product for improving sleep |
| 05/09/2001 | CN1293957A Non-steroid antiinflammatory |
| 05/09/2001 | CN1293956A Preccription for treating gastrosis quickly and radically |
| 05/09/2001 | CN1293955A Anti-infective, antipyretic and antalgic medicine able to treat ophthalmopathy |
| 05/09/2001 | CN1293954A Application of loxoprofen sodium in prepare medicines to treat gynopathy |
| 05/09/2001 | CN1293952A Chitosan and fibroin mixed microsphere and its usage and preparing process |
| 05/09/2001 | CN1065537C Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compsns contg. them |
| 05/09/2001 | CN1065536C Process and crystal form of 2-methyl-thieno-benzodiazepine |
| 05/09/2001 | CN1065535C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 05/09/2001 | CN1065532C Thiazolidine and oxaxoliding derivatives, their prepn. and their medical use |
| 05/09/2001 | CN1065531C Aminotetrazole derivatives useful as nitric oxide synthase inhibotors |
| 05/09/2001 | CN1065524C Substituted phenyl acetanides, process for their prepn. and intermediates thereof |
| 05/09/2001 | CN1065435C Improved external-use medicine having efficient and low by-effect for treating seborrheic baldness |
| 05/09/2001 | CN1065433C Oily prepn. and method of prodn. thereof |
| 05/09/2001 | CN1065429C Alpha-cyclic tetrhydro niacinamide monomucleotide or its probody alpha-cyclic tetrahydro niacinamide adenosin dinucleotide and its prepn. process |
| 05/09/2001 | CN1065428C Matrix type patch preparations |
| 05/08/2001 | US6229048 Helianthrone derivatives as anti-cancer agents |
| 05/08/2001 | US6229031 Method for manufacturing rumen bypass feed supplements |
| 05/08/2001 | US6229029 11β-aryl substituted 14,17-ethanoestratriens, method for the production of these compounds and their use in the production of medicaments |
| 05/08/2001 | US6229026 Reacting an isobenzofuran derivative with grignard reagents 4-halogen-fluorophenyl and 3-halogen-n,n-dimethylpropylamine; causing ring-closure of the product and conversion to 5-cyano derivative |
| 05/08/2001 | US6229025 Process for alkylating hindered sulfonamides |
| 05/08/2001 | US6229016 Method for treating tumors using 2-aryl-naphthyridin-4-ones |
| 05/08/2001 | US6229015 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 05/08/2001 | US6229014 8-azaspiro(4.5)decane-1-one; antidepressants and treatment of psycholigical disorders, specifically memory loss |
| 05/08/2001 | US6229013 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 05/08/2001 | US6229008 α-D-pentofuranosides, and a process for preparing the same |
| 05/08/2001 | US6229002 Complex of nucleic acid which binds to platelet derived growth factor and nonimmunogenic, high molecular weight compound; for targeted diagnostic and therapy; anticarcinogenic agents; cardiovascular disorders; kidney disease |
| 05/08/2001 | US6229001 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 05/08/2001 | US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents |
| 05/08/2001 | US6228894 Softgel-compatible composition containing retinol |
| 05/08/2001 | US6228893 Treating dementia |
| 05/08/2001 | US6228892 Administering 4,5-dihydroxy-2-cyclopenten-1-one |
| 05/08/2001 | US6228891 Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone |
| 05/08/2001 | US6228890 Use of alicyclic diamines as immunomodulators |
| 05/08/2001 | US6228889 Methods for treatment of conditions associated with lactosylceramide |
| 05/08/2001 | US6228888 Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors |
| 05/08/2001 | US6228887 Method of treating skin disorders with high-strength retinoids |
| 05/08/2001 | US6228886 Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents |
| 05/08/2001 | US6228882 Pyronin antibacterials, process and novel intermediates thereto |
| 05/08/2001 | US6228881 Aromatic heterocyclic compounds and their use as anti-inflammatory agents |
| 05/08/2001 | US6228879 Administering 2-phthalimidinoglutaric acid (em-138) to treat vision defects and as antitumor, antimetastasis and anticarcinogenic agent |
| 05/08/2001 | US6228878 Administering indolin-5-one derivatives; inhibiting formation of abnormally phosphorylated paired helical filament epitopes |
| 05/08/2001 | US6228877 Anticarcinogenic, antitumor and antiproliferative agents |
| 05/08/2001 | US6228876 Administering 1-(1,3-dioxolan-2-ylmethy)l- or 1-(1,3-dioxan-2-ylmethyl)-1h-1,2,4-triazole derivative |
| 05/08/2001 | US6228875 Administering derivative of alanine or serine as agonist of nmda receptor; alzheimer*s disease, psychological and nervous system disorders, schizophrenia; cognition activators |
| 05/08/2001 | US6228874 Pharmaceutical composition for angiotensin II-mediated diseases |
| 05/08/2001 | US6228873 Method for enhancing outflow of aqueous humor in treatment of glaucoma |
| 05/08/2001 | US6228872 Neurotrophic diamide and carbamate agents |
| 05/08/2001 | US6228864 Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation |
| 05/08/2001 | US6228863 Mixing orally active agonist and antagonist; two-step extraction required for separation; injection |
| 05/08/2001 | US6228862 Increasing adipocyte differentiation |
| 05/08/2001 | US6228861 Benign prostatic hyperplasia; anticholesterol agents; impotency; intraocular pressure; antiarrhythmia agents |
| 05/08/2001 | US6228860 Substituted 1,3-oxathiolanes with antiviral properties |
| 05/08/2001 | US6228859 Antiasthmatic, antiinflammatory, antiallergen and antidepressant agents |
| 05/08/2001 | US6228858 2,5-methylol-3,6-(aminomethyl)-hydroquinone; diabetes nephropathy; controlling blood sugar |
| 05/08/2001 | US6228855 Topoisomerase inhibitors; antitumor agents |
| 05/08/2001 | US6228853 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/08/2001 | US6228852 Hormone replacement therapy for pre-menopausal ovulatory women; administering native estrogen, progesterone, and testosterone |
| 05/08/2001 | US6228850 Administering as antitumor and anticarcinogenic agents |